Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 506
6
Diseases
8
Unique genes
0.275
Avg. similarity score
Familial ventricular tachycardia
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Familial ventricular tachycardia
Gingival diseases
Ventricular tachycardia
Hypertrichosis, congenital generalised, with gingival hyperplasia
Retractile testis
Hyaline fibromatosis
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Familial ventricular tachycardia | 4 | 4 | 2 |
| Gingival diseases | 4 | 4 | 7 |
| Ventricular tachycardia | 4 | 4 | 2 |
| Hypertrichosis, congenital generalised, with gingival hyperplasia | 3 | 3 | 1 |
| Retractile testis | 2 | 2 | 1 |
| Hyaline fibromatosis | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ABCA5 | 4 / 6 | Familial ventricular tachycardia, Gingival diseases, Hypertrichosis, congenital generalised, with gingival hyperplasia, Ventricular tachycardia |
| GNAI2 | 3 / 6 | Familial ventricular tachycardia, Retractile testis, Ventricular tachycardia |
| ANTXR2 | 2 / 6 | Gingival diseases, Hyaline fibromatosis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Rap1 signaling pathway | KEGG | 4 / 211 | 28.5× | 6.13e-6 | 1.95e-4 ✓ sig. |
| Renin secretion | KEGG | 2 / 69 | 43.5× | 8.91e-4 | 1.04e-2 ✓ sig. |
| Melanoma | KEGG | 2 / 73 | 41.1× | 9.97e-4 | 1.13e-2 ✓ sig. |
| Constitutive Signaling by Aberrant PI3K in Cancer | Reactome | 2 / 75 | 40.0× | 1.05e-3 | 1.18e-2 ✓ sig. |
| Gap junction | KEGG | 2 / 89 | 33.7× | 1.48e-3 | 1.52e-2 ✓ sig. |
| PIP3 activates AKT signaling | Reactome | 2 / 93 | 32.3× | 1.61e-3 | 1.62e-2 ✓ sig. |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | Reactome | 2 / 103 | 29.2× | 1.97e-3 | 1.89e-2 ✓ sig. |
| RAF/MAP kinase cascade | Reactome | 2 / 124 | 24.2× | 2.84e-3 | 2.45e-2 ✓ sig. |
| Pathways in cancer | KEGG | 3 / 533 | 8.4× | 4.12e-3 | 3.19e-2 ✓ sig. |
| cGMP-PKG signaling pathway | KEGG | 2 / 166 | 18.1× | 5.03e-3 | 3.66e-2 ✓ sig. |
| Formyl peptide receptors bind formyl peptides and many other ligands | Reactome | 1 / 8 | 188× | 5.32e-3 | 3.80e-2 ✓ sig. |
| Ca2+ activated K+ channels | Reactome | 1 / 9 | 167× | 5.98e-3 | 4.10e-2 ✓ sig. |
| FGFR2b ligand binding and activation | Reactome | 1 / 10 | 150× | 6.64e-3 | 4.39e-2 ✓ sig. |
| PLC beta mediated events | Reactome | 1 / 12 | 125× | 7.97e-3 | 4.94e-2 ✓ sig. |
| Chemical carcinogenesis - receptor activation | KEGG | 2 / 215 | 14.0× | 8.32e-3 | 5.07e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of cell division | GO:0051781 | 2 / 48 | 97.3× | 1.79e-4 | 4.70e-3 ✓ sig. |
| positive chemotaxis | GO:0050918 | 2 / 51 | 91.6× | 2.02e-4 | 5.14e-3 ✓ sig. |
| positive regulation of vascular associated smooth muscle cell proliferation | GO:1904707 | 2 / 53 | 88.1× | 2.19e-4 | 5.40e-3 ✓ sig. |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway | GO:0007188 | 2 / 57 | 82.0× | 2.53e-4 | 6.00e-3 ✓ sig. |
| positive regulation of endothelial cell proliferation | GO:0001938 | 2 / 69 | 67.7× | 3.71e-4 | 7.80e-3 ✓ sig. |
| metanephric glomerular mesangial cell development | GO:0072255 | 1 / 1 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| positive regulation of metanephric mesenchymal cell migration | GO:2000591 | 1 / 1 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| response to wounding | GO:0009611 | 2 / 81 | 57.7× | 5.11e-4 | 9.64e-3 ✓ sig. |
| cellular response to mycophenolic acid | GO:0071506 | 1 / 2 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| positive regulation of reverse cholesterol transport | GO:1903064 | 1 / 2 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| negative regulation of phosphatidylinositol biosynthetic process | GO:0010512 | 1 / 2 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| positive regulation of TRAIL production | GO:0032759 | 1 / 2 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| positive regulation of cell population proliferation | GO:0008284 | 3 / 532 | 13.2× | 1.15e-3 | 1.58e-2 ✓ sig. |
| positive regulation of glomerular filtration | GO:0003104 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| secretion by lung epithelial cell involved in lung growth | GO:0061033 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Familial ventricular tachycardia | Ventricular tachycardia | 0.667 | 2 | 8.34e-9 | 6.60e-8 ✓ sig. |
| Familial ventricular tachycardia | Retractile testis | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Familial ventricular tachycardia | Hypertrichosis, congenital generalised, with gingival hyperplasia | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Hypertrichosis, congenital generalised, with gingival hyperplasia | Ventricular tachycardia | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Retractile testis | Ventricular tachycardia | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Gingival diseases | Hyaline fibromatosis | 0.125 | 1 | 4.52e-4 | 8.26e-4 ✓ sig. |
| Gingival diseases | Hypertrichosis, congenital generalised, with gingival hyperplasia | 0.125 | 1 | 4.52e-4 | 8.26e-4 ✓ sig. |
| Familial ventricular tachycardia | Gingival diseases | 0.111 | 1 | 9.04e-4 | 1.41e-3 ✓ sig. |
| Gingival diseases | Ventricular tachycardia | 0.111 | 1 | 9.04e-4 | 1.41e-3 ✓ sig. |